1 result for "Antonio Rosato"
Add this URL to any RSS reader. Updated daily.
HA-Paclitaxel Conjugate Patent for Treatment of Mesothelioma
USPTO granted Patent US12605355B2 to Fidia Farmaceutici S.p.A. covering HA-paclitaxel conjugate compositions for loco-regional treatment of malignant mesothelioma. The patent, with 13 claims, covers malignant pleural, pericardial, and peritoneal mesothelioma applications, with priority dating to the April 7, 2021 filing.
Routine
Rule
Intellectual Property
Get alerts for "Antonio Rosato"
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Browse Categories
Agriculture & Food Safety
73
AI Regulation
3
Banking & Finance
414
Consumer Protection
89
Courts & Legal
411
Data Privacy & Cybersecurity
90
Defense & National Security
53
Education
55
Energy
100
Environment
152
Gaming
2
Government & Legislation
431
Healthcare
15
Healthcare & Life Sciences
375
Immigration
10
Insurance
76
Labor & Employment
138
Pharma & Drug Safety
21
Professional Licensing
8
Real Estate & Housing
78
Securities & Markets
154
Tax
78
Telecom & Technology
47
Trade & Sanctions
141
Transportation
91
Get alerts for "Antonio Rosato"
We'll email you when new changes match "Antonio Rosato".
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.
You're subscribed!